Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road
Translational Cancer Research · 2025-02 · 14 (2) · 679-684
DOI: 10.21037/tcr-24-1870 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Cancer Research, 2025-02. Verfasst von Robert Hsu. Beteiligte Einrichtung: Division of Medical Oncology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Medicine, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Robert Hsu
Zitieren
APA
Hsu, R. (2025). Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road. Translational Cancer Research, 14(2), 679-684. https://doi.org/10.21037/tcr-24-1870
Vancouver
Hsu R. Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road. Translational Cancer Research. 2025;14(2):679-684. doi:10.21037/tcr-24-1870
BibTeX
@article{Hsu2025,
author = {Hsu, Robert},
title = {Deciding where Trop-2 directed antibody drug conjugates work in non-small cell lung cancer: the not so straightforward road},
journal = {Translational Cancer Research},
year = {2025},
volume = {14},
number = {2},
pages = {679--684},
doi = {10.21037/tcr-24-1870}
}
EUVIMED